Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.
Preet A, Ganju RK, Groopman JE. Preet A, et al. Oncogene. 2008 Jan 10;27(3):339-46. doi: 10.1038/sj.onc.1210641. Epub 2007 Jul 9. Oncogene. 2008. PMID: 17621270
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
Preet A, Qamri Z, Nasser MW, Prasad A, Shilo K, Zou X, Groopman JE, Ganju RK. Preet A, et al. Cancer Prev Res (Phila). 2011 Jan;4(1):65-75. doi: 10.1158/1940-6207.CAPR-10-0181. Epub 2010 Nov 19. Cancer Prev Res (Phila). 2011. PMID: 21097714 Free PMC article.
Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
Qamri Z, Preet A, Nasser MW, Bass CE, Leone G, Barsky SH, Ganju RK. Qamri Z, et al. Among authors: preet a. Mol Cancer Ther. 2009 Nov;8(11):3117-29. doi: 10.1158/1535-7163.MCT-09-0448. Epub 2009 Nov 3. Mol Cancer Ther. 2009. PMID: 19887554 Free PMC article.
Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.
Ghosh S, Preet A, Groopman JE, Ganju RK. Ghosh S, et al. Among authors: preet a. Mol Immunol. 2006 Jul;43(14):2169-79. doi: 10.1016/j.molimm.2006.01.005. Epub 2006 Feb 28. Mol Immunol. 2006. PMID: 16503355
Slit-2 induces a tumor-suppressive effect by regulating beta-catenin in breast cancer cells.
Prasad A, Paruchuri V, Preet A, Latif F, Ganju RK. Prasad A, et al. Among authors: preet a. J Biol Chem. 2008 Sep 26;283(39):26624-33. doi: 10.1074/jbc.M800679200. Epub 2008 Jul 8. J Biol Chem. 2008. PMID: 18611862 Free PMC article.
Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon.
Natarajan TG, Kallakury BV, Sheehan CE, Bartlett MB, Ganesan N, Preet A, Ross JS, FitzGerald KT. Natarajan TG, et al. Among authors: preet a. Cancer Cell Int. 2010 Apr 30;10:13. doi: 10.1186/1475-2867-10-13. Cancer Cell Int. 2010. PMID: 20433758 Free PMC article.
SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.
Kolukula VK, Sahu G, Wellstein A, Rodriguez OC, Preet A, Iacobazzi V, D'Orazi G, Albanese C, Palmieri F, Avantaggiati ML. Kolukula VK, et al. Among authors: preet a. Oncotarget. 2014 Mar 15;5(5):1212-25. doi: 10.18632/oncotarget.1831. Oncotarget. 2014. PMID: 24681808 Free PMC article.
Dissecting the pathways that destabilize mutant p53: the proteasome or autophagy?
Choudhury S, Kolukula VK, Preet A, Albanese C, Avantaggiati ML. Choudhury S, et al. Among authors: preet a. Cell Cycle. 2013 Apr 1;12(7):1022-9. doi: 10.4161/cc.24128. Epub 2013 Mar 6. Cell Cycle. 2013. PMID: 23466706 Free PMC article.
Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy.
Rodriguez OC, Choudhury S, Kolukula V, Vietsch EE, Catania J, Preet A, Reynoso K, Bargonetti J, Wellstein A, Albanese C, Avantaggiati ML. Rodriguez OC, et al. Among authors: preet a. Cell Cycle. 2012 Dec 1;11(23):4436-46. doi: 10.4161/cc.22778. Epub 2012 Nov 14. Cell Cycle. 2012. PMID: 23151455 Free PMC article.
Tissue and serum microRNAs in the Kras(G12D) transgenic animal model and in patients with pancreatic cancer.
LaConti JJ, Shivapurkar N, Preet A, Deslattes Mays A, Peran I, Kim SE, Marshall JL, Riegel AT, Wellstein A. LaConti JJ, et al. Among authors: preet a. PLoS One. 2011;6(6):e20687. doi: 10.1371/journal.pone.0020687. Epub 2011 Jun 27. PLoS One. 2011. PMID: 21738581 Free PMC article.
20 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page